dm+d

27479000

Medicine Compliance Aid Stability

RetrovirViiV Healthcare UK Ltd

ViiV Healthcare UK Ltd
Retrovir
Capsules 100mg 250mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Protect from moisture
Zidovudine not adversely affected by short-term exposure to heat and sunlight. Capsules may become discolored or brittle and should be protected from light, heat, and moisture.
18 August 2015